• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Dementia rates dropping
Conclusion This study suggests that the prevalence of dementia in over 65s in 2011 is lower than would have been expected.  The study had many strengths, including the large number of people it interviewed from different areas and the consistent research methods adopted in 1991 and again in 2011, particularly using the same criteria to diagnose dementia at both time points. This means we can be relatively sure that its conclusions are reliable. That said, it does have some limitations to consider. The response rate in 2011 (56%) was much lower than in 1991 (80%). The study authors offer a number of explanations for this...
Source: NHS News Feed - July 17, 2013 Category: Consumer Health News Tags: Neurology Older people Medical practice Source Type: news

ACE inhibitor use may be linked to kidney failure
Conclusion ACE inhibitors and ARAs are recognised as a potential risk factor for AKI in some patients. This particular study has tried to estimate the possible size of the problem, but its findings should be viewed with some caution. As the authors point out: some of the conditions these drugs are prescribed for are themselves a risk factor for AKI changes in hospital coding and better recognition of AKI could explain the rise in admissions an ageing population leads to both increased prescribing of these drugs and an increased risk for AKI increased use of these drugs may be a marker for increased use of other...
Source: NHS News Feed - November 7, 2013 Category: Consumer Health News Tags: Medication Heart/lungs Source Type: news

Tech titans gather to make winners of the 'Oscars of science' into instant millionaires
Silicon Valley hosts lavish ceremony for Breakthrough prize that aims to give scientists celebrity status and inspire interest in life's 'big questions'Silicon Valley has a tendency to tackle social ills with big ideas, its feisty startups revolutionising everything from healthcare to education. Now a handful of billionaire engineers have turned their attention to a social blight that affects their own kind: the lack of appreciation (and funding) for scientists.The second Breakthrough prize for life sciences is being awarded on Thursday at Nasa's Ames Research Centre in Mountain View, California, about a five-minute drive ...
Source: Guardian Unlimited Science - December 7, 2013 Category: Science Authors: Parmy Olson Tags: United States Culture World news Mark Zuckerberg Media Kevin Spacey Sergey Brin Technology Science prizes UK news Film California The Observer Glenn Close Source Type: news

Tricks to Treatments: Sensory Tricks in Dystonia (P2.042)
CONCLUSIONS:We propose a new classification of ST,to include its variants, such as FT, MT, IT and rST. Wide range of prevalence and effectiveness of ST may reflect ambiguity of terminology and varying measures. More studies are needed to determine the interaction of deep brain stimulation and botulinum toxin with ST. Our research points to more benefit than harm for searching for, or even inducing, ST in patients with dystonia.Study Supported by:National Institutes of Health and the National Institute of Neurological Disorders and Stroke, and the the Dystonia Medical Research Foundation.Disclosure: Dr. Ramos has received p...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Ramos, V., Karp, B., Hallett, M. Tags: Movement Disorders: Dystonia Source Type: research

Response to IncobotulinumtoxinA After Resistance to OnabotulinumtoxinA and RimabotulinumtoxinB (P7.061)
CONCLUSIONS:Switching to incobotulinumtoxinA after secondary resistance to onabotulinumtoxinA and rimabotulinumtoxinB may be a viable treatment option in dystonia.Study Supported by:National Institutes of Health- National Institutes of Neurological Diseases and Stroke and the Dystonia Medical Research FoundationDisclosure: Dr. Ramos has received personal compensation for activities with the National Inistitutes of Health as an employee, and the Dystonia Medical Research Foundation. Dr. Karp has nothing to disclose. Dr. Lungu has nothing to disclose. Dr. Alter has nothing to disclose. Dr. Hallett has received personal compe...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Ramos, V., Karp, B., Lungu, C., Alter, K., Hallett, M. Tags: Movement Disorders: Dystonia Treatment Source Type: research

The Stroke Book, 2nd Edition. Michel T. Torbey, MD, MPH, and Magdy H. Selim, MD, PhD. Cambridge, UK: Cambridge University Press, 2013; 380 pp; $59.95 (softcover).
Source: Academic Emergency Medicine - September 30, 2014 Category: Emergency Medicine Authors: Kathleen Cowling, Warren Singleton Tags: Media Reviews Source Type: research

Neural correlates of action recognition and object knowledge in neurodegenerative disease (P6.196)
CONCLUSIONS: Our results suggest that action recognition is supported by a distributed left lateralized functional network that exhibits dissociable roles. In particular, left mid-posterior temporal and inferior parietal areas seem critical for representation of the gestural component of action recognition while frontal inferior regions may support cognitive control requirements common to all 3 tests.Disclosure: Dr. santos has nothing to disclose. Dr. Illan-Gala has nothing to disclose. Dr. Vinceti has nothing to disclose. Dr. Mandelli has nothing to disclose. Dr. Hubbard has nothing to disclose. Dr. Miller has nothing to ...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Santos, M., Illan-Gala, I., Vinceti, G., Mandelli, M. L., Hubbard, H., Miller, Z., Rabinovici, G., Miller, B., Gorno Tempini, M. Tags: Aging, Dementia, Cognitive, and Behavioral Neurology: Neuropsychiatry and Behavioral Neurology Source Type: research

Promoting Locomotor Learning with Spinal Direct Current Stimulation- Pilot Data (S28.005)
CONCLUSION: After interim analysis, we repowered the study and determined that 14 additional healthy volunteers per group will be needed, to achieve a statistical significance of 97.5 percent and a power of 0.80. Results gathered at this stage will allow us to further assess the effect of tDCS at different stages of locomotor learning, including online, offline, and total learning-- necessary for application in future neurorehabilitation trials involving patients with spinal cord injury and stroke. Study Supported by: Intramural Research Program, NINDSDisclosure: Dr. Awosika has nothing to disclose. Dr. Sandrini has nothin...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Awosika, O., Sandrini, M., Volochayev, R., Xu, B., Floeter, M. K., Hallett, M., Cohen, L. Tags: Neuro-rehabilitation Source Type: research

Increased Minimum Mortality Temperature in France: Data Suggest Humans Are Adapting to Climate Change
Julia R. Barrett, MS, ELS, a Madison, WI–based science writer and editor, is a member of the National Association of Science Writers and the Board of Editors in the Life Sciences. About This Article open Citation: Barrett JR. 2015. Increased minimum mortality temperature in France: data suggest humans are adapting to climate change. Environ Health Perspect 123:A184; http://dx.doi.org/10.1289/ehp.123-A184 News Topics: Climate Change, Temperature Published: 1 July 2015 PDF Version (334 KB) Related EHP Article Space–Time Covariation of Mortality with Temperature: A Systematic Study of Deaths in France, 196...
Source: EHP Research - July 1, 2015 Category: Environmental Health Authors: Web Admin Tags: Featured News Science Selection Climate Change July 2015 Temperature Source Type: research

Being overweight, smoking and drinking ‘cuts lifespan by 23 years’
The reduction in lifespan from a combination of diabetes, heart attack and a stroke is similar to that of people diagnosed with HIV, scientists from Cambridge University found.
Source: the Mail online | Health - July 8, 2015 Category: Consumer Health News Source Type: news

Lessons Learned From Trends in Insufficient Sleep Across the United States
This article originally appeared on the Amerisleep blog. Rosie Osmun is the Creative Content Manager at Amerisleep, a progressive memory foam mattress brand focused on eco-friendly sleep solutions. Rosie writes more posts on the Amerisleep blog about the science of sleep, eco-friendly living, leading a healthy lifestyle and more. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.
Source: Healthy Living - The Huffington Post - October 16, 2015 Category: Consumer Health News Source Type: news

Our Sedentary Lifestyles Cost About 5 Million Lives A Year
By Kate Kelland LONDON (Reuters) - A study of one million people has found that physical inactivity costs the global economy $67.5 billion a year in healthcare and productivity losses, but an hour a day of exercise could eliminate most of that. Sedentary lifestyles are linked to increased risks of heart disease, diabetes and cancer, researchers found, but activity - such as brisk walking - could counter the higher likelihood of early death linked with sitting for eight or more hours a day. Such inactivity is estimated to cause more than 5 million deaths a year - almost as many as smoking, which the World Health Organi...
Source: Science - The Huffington Post - July 28, 2016 Category: Science Source Type: news

A Mediterranean diet in the UK would save 20,000 lives a year as one in eight deaths from heart attack and stroke could be prevented by the change
Researchers from Cambridge University evaluated the effects of an olive oil, fish and nut-rich diet on the health of ordinary people in England - and found it could prevent deaths.
Source: the Mail online | Health - September 29, 2016 Category: Consumer Health News Source Type: news

Two older drugs could be 'repurposed' to fight dementia
Conclusion This early stage experimental research has demonstrated a beneficial neurological effect of trazodone and dibenzoylmethane on mice with diseases mimicking neurodegenerative diseases. It is important to acknowledge that this is animal research and therefore the drugs might not have the same effect when they are trialled on humans. That being said, trazodone is already an approved drug for depression and sleep problems and has therefore already passed safety tests. If the mechanisms of neurodegeneration in humans and mice are similar, it is possible trazodone could be used in the future in treating Alzheimer's and...
Source: NHS News Feed - April 20, 2017 Category: Consumer Health News Tags: Older people Neurology Medication Source Type: news

Pages: 1  2  3